Paper37012015
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial).
Zoungas S and 17 others. BMJ Open, 2023. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial). Papers, record 37012015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37012015
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial).
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Cardiovascular Diseases | Major topic |
| Myocardial Infarction | Major topic |
| Stroke | Major topic |
| Dementia | Major topic |
| Aged | |
| Humans | |
| Aged, 80 and over | |
| Quality of Life | |
| Australia | |
| Primary Prevention | |
| Primary Health Care | |
| Randomized Controlled Trials as Topic |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02099123 | A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) | Derived from the trial | Yes |
Source ClinicalTrials.gov
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15673344 | Relationship between plasma lipids and all-cause mortality in nondemented elderly. | J Am Geriatr Soc | 2005 | https://conductscience.org/library/papers/15673344 | PubMed |
| 2 | 31752701 | Disability incidence and functional decline among older adults with major chronic diseases. | BMC Geriatr | 2019 | https://conductscience.org/library/papers/31752701 | PubMed |
| 3 | 16291918 | Epidemiology and risk factors of dementia. | J Neurol Neurosurg Psychiatry | 2005 | https://conductscience.org/library/papers/16291918 | PubMed |
| 4 | 23529608 | Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials. | Eur J Prev Cardiol | 2013 | https://conductscience.org/library/papers/23529608 | PubMed |
| 5 | 24866986 | Statins in the elderly: an answered question? | Curr Opin Cardiol | 2014 | https://conductscience.org/library/papers/24866986 | PubMed |
| 6 | 28385949 | Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials. | Circulation | 2017 | https://conductscience.org/library/papers/28385949 | PubMed |
| 7 | 15803163 | Statins--a cure-all for the brain? | Nat Rev Neurosci | 2005 | https://conductscience.org/library/papers/15803163 | PubMed |
| 8 | 11559371 | The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. | J Am Geriatr Soc | 2001 | https://conductscience.org/library/papers/11559371 | PubMed |
| 9 | 28168689 | Effect of Physical Activity on Self-Reported Disability in Older Adults: Results from the LIFE Study. | J Am Geriatr Soc | 2017 | https://conductscience.org/library/papers/28168689 | PubMed |
| 10 | 30586759 | Quantifying Importance of Major Risk Factors for Coronary Heart Disease. | Circulation | 2019 | https://conductscience.org/library/papers/30586759 | PubMed |
| 11 | 32616158 | Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults. | J Am Coll Cardiol | 2020 | https://conductscience.org/library/papers/32616158 | PubMed |
| 12 | 19801098 | Ageing populations: the challenges ahead. | Lancet | 2009 | https://conductscience.org/library/papers/19801098 | PubMed |
| 13 | 30221597 | Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30221597 | PubMed |
| 14 | 30003171 | Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial. | Contemp Clin Trials Commun | 2018 | https://conductscience.org/library/papers/30003171 | PubMed |
| 15 | 19770150 | Human population growth and the demographic transition. | Philos Trans R Soc Lond B Biol Sci | 2009 | https://conductscience.org/library/papers/19770150 | PubMed |
| 16 | 18061058 | Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. | Lancet | 2007 | https://conductscience.org/library/papers/18061058 | PubMed |
| 17 | 27838724 | Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. | JAMA | 2016 | https://conductscience.org/library/papers/27838724 | PubMed |
| 18 | 18449611 | Prevalence of musculoskeletal pain and statin use. | J Gen Intern Med | 2008 | https://conductscience.org/library/papers/18449611 | PubMed |
| 19 | 25313241 | Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing. | Age Ageing | 2015 | https://conductscience.org/library/papers/25313241 | PubMed |
| 20 | 30355005 | Updated Criteria for Population-Based Stroke and Transient Ischemic Attack Incidence Studies for the 21st Century. | Stroke | 2018 | https://conductscience.org/library/papers/30355005 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42825089 | Association between timing of statin treatment after diabetes diagnosis and risk of dementia: a nationwide observational study. | Lancet Reg Health Eur | 2026 | https://conductscience.org/library/papers/42825089 | PubMed |
| 42818935 | Multi-trait Polygenic Profiling and Survival Free of Dementia and Disability: Results from the Health and Retirement Study. | medRxiv | 2026 | https://conductscience.org/library/papers/42818935 | PubMed |
| 42728062 | Deprescribing statins for adults 65 years of age and older: Evidence-based clinical practice guideline. | Can Fam Physician | 2026 | https://conductscience.org/library/papers/42728062 | PubMed |
| 42461299 | [Austrian lipid consensus : Interdisciplinary evidence-based recommendations on prevention and treatment of lipid-associated diseases from 15 medical specialist societies]. | Wien Klin Wochenschr | 2026 | https://conductscience.org/library/papers/42461299 | PubMed |
| 42396578 | LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisions. | Atheroscler Plus | 2026 | https://conductscience.org/library/papers/42396578 | PubMed |
| 42340940 | Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study. | PLoS Med | 2026 | https://conductscience.org/library/papers/42340940 | PubMed |
| 42291043 | Statin use and cognitive outcomes in older adults. | Am J Prev Cardiol | 2026 | https://conductscience.org/library/papers/42291043 | PubMed |
| 42203295 | Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trial. | BMJ Open | 2026 | https://conductscience.org/library/papers/42203295 | PubMed |
| 42100682 | Lipid-lowering therapy for primary prevention of cardiovascular disease in adults aged 75 years and older: a narrative review. | Int J Cardiol Cardiovasc Risk Prev | 2026 | https://conductscience.org/library/papers/42100682 | PubMed |
| 41732846 | Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events. | Ann Med | 2026 | https://conductscience.org/library/papers/41732846 | PubMed |
| 41718130 | Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/41718130 | PubMed |
| 41645316 | Investigating estimand considerations in adaptive trials: a systematic review. | Trials | 2026 | https://conductscience.org/library/papers/41645316 | PubMed |
| 41478887 | Optimizing cardiovascular pharmacotherapy in older adults with frailty. | Nat Rev Cardiol | 2026 | https://conductscience.org/library/papers/41478887 | PubMed |
| 41400788 | Lipid-Lowering Therapies and Cognition in Older Adults: A Narrative Review and Clinical Considerations. | Curr Cardiol Rep | 2025 | https://conductscience.org/library/papers/41400788 | PubMed |
| 40924377 | Cardiovascular Risk Prediction in Older Adults. | Curr Atheroscler Rep | 2025 | https://conductscience.org/library/papers/40924377 | PubMed |
| 40869565 | Statin Treatment for Reducing Mortality Risk in Individuals over 75 Years of Age: A Large-Scale Retrospective Analysis. | J Clin Med | 2025 | https://conductscience.org/library/papers/40869565 | PubMed |
| 40801072 | In the wake of the Scandinavian Simvastatin Survival Study trial. | Curr Opin Lipidol | 2025 | https://conductscience.org/library/papers/40801072 | PubMed |
| 40409969 | Rationale and design of 'discontinuing statins in multimorbid older adults without cardiovascular disease (STREAM)': study protocol of a randomised non-inferiority clinical trial. | BMJ Open | 2025 | https://conductscience.org/library/papers/40409969 | PubMed |
| 40338434 | Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly. | Drugs | 2025 | https://conductscience.org/library/papers/40338434 | PubMed |
| 40294956 | SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials. | BMJ | 2025 | https://conductscience.org/library/papers/40294956 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| HMGCR | 3156 | PubTator's text mining | https://conductscience.org/library/genes/3156 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| ATORVASTATIN | CHEMBL1487 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1487 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37012015
GET https://conductscience.org/api/papers/v1/37012015/references?page=2